ExodusPoint Capital Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-68,000
| Closed | -$220K | – | 1842 |
|
2024
Q3 | $220K | Buy |
+68,000
| New | +$220K | ﹤0.01% | 1323 |
|
2022
Q4 | – | Sell |
-29,786
| Closed | -$1.1M | – | 1990 |
|
2022
Q3 | $1.1M | Buy |
29,786
+11,531
| +63% | +$427K | 0.01% | 1039 |
|
2022
Q2 | $347K | Buy |
+18,255
| New | +$347K | ﹤0.01% | 1436 |
|
2020
Q2 | – | Sell |
-28,252
| Closed | -$964K | – | 1948 |
|
2020
Q1 | $964K | Buy |
28,252
+16,497
| +140% | +$563K | 0.05% | 278 |
|
2019
Q4 | $458K | Buy |
+11,755
| New | +$458K | 0.01% | 850 |
|